Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Innovation Pharmaceuticals Inc IPIX

Innovation Pharmaceuticals Inc. is a clinical stage pharmaceutical company developing therapies with anti-infective, oncology, anti-inflammatory and dermatology applications. The Company’s lead drug candidate, Brilacidin, is in a class of compounds called defensin-mimetics, small compounds that mimic the structure and function of defensins, also known as host defense peptides. The Company is primarily focused on business development for the advancement of Brilacidin in the treatment of infectious diseases and oral mucositis. Its ongoing activities include Brilacidin drug manufacturing, scientific report writing, and supportive research activities. Brilacidin is also developed as a treatment in more extensive forms of inflammatory bowel disease (IBD). It is engaged in developing an image guided surgical laser platform, through BT BeaMedical Technologies Ltd. It is also engaged in business development and licensing initiatives with specialty and global pharmaceutical companies.


GREY:IPIX - Post by User

Comment by kaos12on Apr 11, 2019 3:16pm
120 Views
Post# 29614696

RE:RE:Is Leo about to make his deal?

RE:RE:Is Leo about to make his deal?If we get a partnership SOON funding problems will be behind us and we can start or continue work on Kevetrin, which I think is an even bigger and better deal than Brilacidin. If one takes all of the possible verticals with Brilacidin then I figure B and K could be fairly equal in terms of revenues which would be massive and IPIX would become a multi billion dollar MC company quite handily. I have heard from sources that people close to Leo figure we could see $100/ share in the future with B and K. These same people figure we could get to $3-4 on partnership announcement. Others have said $3-4, $7-9, and even $9-20. I’m not pumping this, just repeating what I have read and heard. If you are interested in IPIX and want some very good comments on what is happening it seems that InvestorsHub has a lot of very qualified people on the bull board. GLTA. 
<< Previous
Bullboard Posts
Next >>